Article Versions Notes

Ding L, Bar-Shalom R, Aharonovich D, Kurisawa N, Patial G, Li S, He S, Yan X, Iwasaki A, Suenaga K, et al. Metabolomic Characterization of a cf. Neolyngbya Cyanobacterium from the South China Sea Reveals Wenchangamide A, a Lipopeptide with In Vitro Apoptotic Potential in Colon Cancer Cells. Marine Drugs. 2021; 19(7):397. https://doi.org/10.3390/md19070397

Ding, Lijian, Rinat Bar-Shalom, Dikla Aharonovich, Naoaki Kurisawa, Gaurav Patial, Shuang Li, Shan He, Xiaojun Yan, Arihiro Iwasaki, Kiyotake Suenaga, and et al. 2021. "Metabolomic Characterization of a cf. Neolyngbya Cyanobacterium from the South China Sea Reveals Wenchangamide A, a Lipopeptide with In Vitro Apoptotic Potential in Colon Cancer Cells" Marine Drugs 19, no. 7: 397. https://doi.org/10.3390/md19070397

Ding, L., Bar-Shalom, R., Aharonovich, D., Kurisawa, N., Patial, G., Li, S., He, S., Yan, X., Iwasaki, A., Suenaga, K., Zhu, C., Luo, H., Tian, F., Fares, F., Naman, C. B., & Luzzatto-Knaan, T. (2021). Metabolomic Characterization of a cf. Neolyngbya Cyanobacterium from the South China Sea Reveals Wenchangamide A, a Lipopeptide with In Vitro Apoptotic Potential in Colon Cancer Cells. Marine Drugs, 19(7), 397. https://doi.org/10.3390/md19070397